Company / Return on Assets (ROA)
Design Therapeutics, Inc. Return on Assets (ROA) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-21.9%
FY2025
5-year range
-26.5% / -2.1%
FY2021-FY2025
Trend
+17.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -2.1% to -21.9% over the past 4 years.
Based on SEC 10-K filings.
-21.9% in FY2025.
Declined from -2.1% to -21.9% over the past 4 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 17.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -21.9% | +17.3% |
| FY2024 | -26.5% | -1150.9% |
| FY2021 | -2.1% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026